BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11607772)

  • 1. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Residual placental blood and bone marrow as sources of hematopoietic stem cells for allogenic stem cell transplantation. Comparative analysis of hematopoietic potential].
    Köhler A; Häfer R; Müller A; Zintl F
    Klin Padiatr; 1995; 207(4):215-8. PubMed ID: 7564155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
    Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel PG
    Bone Marrow Transplant; 2003 Aug; 32(4):379-90. PubMed ID: 12900774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
    Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
    Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohammed R
    Exp Hematol; 1997 Jun; 25(6):471-7. PubMed ID: 9197323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
    Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
    Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
    Spencer A; Jackson J; Baulch-Brown C
    Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypic differences between CD34 positive cells in various transplantation tissues].
    Fritsch G; Stimpfl M; Leitner A; Printz D; Buchinger P; Mann G; Peters C; Zoubek A; Gadner H
    Klin Padiatr; 1995; 207(4):211-4. PubMed ID: 7564154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
    Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
    Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of alpha2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1(lo)c-kit+ Sca-1+ hematopoietic stem cells.
    Wagers AJ; Weissman IL
    Stem Cells; 2006 Apr; 24(4):1087-94. PubMed ID: 16373693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells.
    Zanjani ED; Almeida-Porada G; Livingston AG; Flake AW; Ogawa M
    Exp Hematol; 1998 Apr; 26(4):353-60. PubMed ID: 9546319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
    Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
    Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.
    Kim SK; Koh SK; Song SU; Shin SH; Choi GS; Kim WC; Lee MH; Seoh JY; Park SK; Fraser JK
    Mol Cells; 2002 Dec; 14(3):367-73. PubMed ID: 12521299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.